Researchmoz added Most up-to-date research on "Point-of-Care Genetic Testing Market: Global Industry Analysis, Research, Size, Share, Growth, Sales, Trends and Forecast to 2025" to its huge collection of research reports.
In 2017, the global Point-of-Care Genetic Testing market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.
This report focuses on the global Point-of-Care Genetic Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Point-of-Care Genetic Testing development in United States, Europe and China.
The key players covered in this study
Abbott (US)
Roche (Switzerland)
Thermo Fisher Scientific (US)
Cepheid (US)
IQuum (US)
Biocartis (Switzerland)
Idaho Technologies (US)
Optigene (UK)
Lumora (UK)
Market segment by Type, the product can be split into
POCT Cancer Kits
Molecular POC Kits
POCT In Antibiotic Therapies
Assay Cartridge
Other
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1920331
Market segment by Application, split into
Diagnostic Labs
Bio-Pharmaceutical Industry
Academic Institutions
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Point-of-Care Genetic Testing status, future forecast, growth opportunity, key market and key players.
To present the Point-of-Care Genetic Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
Browse TOC @ https://www.researchmoz.us/global-point-of-care-genetic-testing-market-size-status-and-forecast-2018-2025-report.html/toc
In this study, the years considered to estimate the market size of Point-of-Care Genetic Testing are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
In 2017, the global Point-of-Care Genetic Testing market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.
This report focuses on the global Point-of-Care Genetic Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Point-of-Care Genetic Testing development in United States, Europe and China.
The key players covered in this study
Abbott (US)
Roche (Switzerland)
Thermo Fisher Scientific (US)
Cepheid (US)
IQuum (US)
Biocartis (Switzerland)
Idaho Technologies (US)
Optigene (UK)
Lumora (UK)
Market segment by Type, the product can be split into
POCT Cancer Kits
Molecular POC Kits
POCT In Antibiotic Therapies
Assay Cartridge
Other
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1920331
Market segment by Application, split into
Diagnostic Labs
Bio-Pharmaceutical Industry
Academic Institutions
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Point-of-Care Genetic Testing status, future forecast, growth opportunity, key market and key players.
To present the Point-of-Care Genetic Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
Browse TOC @ https://www.researchmoz.us/global-point-of-care-genetic-testing-market-size-status-and-forecast-2018-2025-report.html/toc
In this study, the years considered to estimate the market size of Point-of-Care Genetic Testing are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
No comments:
Post a Comment